Stockreport

Vaxcyte Inc (PCVX)'s VAX-31 Enters Critical Trial Stage [Yahoo! Finance]

Vaxcyte, Inc.  (PCVX) 
PDF The company announced this development on March 23, stating that it enrolled approximately 4,000 participants in the OPUS-1 trial and 1,300 in the OPUS-2 trial. Vaxcyt [Read more]